Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma

Name: Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma
License: Public Domain

City of Hope Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

high grade b-cell non-hodgkin's lymphoma, intermediate grade b-cell non-hodgkin's lymphoma, recurrent b-cell non-hodgkin lymphoma, refractory b-cell non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230466
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.